167 related articles for article (PubMed ID: 25152339)
1. Impact of hyperhidrosis on quality of life and its assessment.
Hamm H
Dermatol Clin; 2014 Oct; 32(4):467-76. PubMed ID: 25152339
[TBL] [Abstract][Full Text] [Related]
2. Special considerations for children with hyperhidrosis.
Bohaty BR; Hebert AA
Dermatol Clin; 2014 Oct; 32(4):477-84. PubMed ID: 25152340
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with botulinum toxin type A: a case series.
Kouris A; Armyra K; Stefanaki C; Christodoulou C; Karimali P; Kontochristopoulos G
Pediatr Dermatol; 2015; 32(2):226-30. PubMed ID: 25557249
[TBL] [Abstract][Full Text] [Related]
4. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
[TBL] [Abstract][Full Text] [Related]
5. Primary focal hyperhidrosis: scope of the problem.
Glaser DA; Hebert AA; Pariser DM; Solish N
Cutis; 2007 May; 79(5 Suppl):5-17. PubMed ID: 17596096
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.
Weber A; Heger S; Sinkgraven R; Heckmann M; Elsner P; Rzany B
Br J Dermatol; 2005 Feb; 152(2):342-5. PubMed ID: 15727649
[TBL] [Abstract][Full Text] [Related]
7. Differences between objective efficacy and perceived efficacy in patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy.
Alvarez MA; Ruano J; Gómez FJ; Casas E; Baamonde C; Salvatierra A; Moreno JC
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e282-8. PubMed ID: 22827710
[TBL] [Abstract][Full Text] [Related]
8. Long-term results and quality-of-life measures in the management of hyperhidrosis.
Cetindag IB; Boley TM; Webb KN; Hazelrigg SR
Thorac Surg Clin; 2008 May; 18(2):217-22. PubMed ID: 18557594
[TBL] [Abstract][Full Text] [Related]
9. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
Solish N; Benohanian A; Kowalski JW;
Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
[TBL] [Abstract][Full Text] [Related]
10. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis.
Ambrogi V; Campione E; Mineo D; Paternò EJ; Pompeo E; Mineo TC
Ann Thorac Surg; 2009 Jul; 88(1):238-45. PubMed ID: 19559233
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial functioning of patients after endoscopic thoracic sympathectomy.
Vazquez LD; Staples NL; Sears SF; Klodell CT
Eur J Cardiothorac Surg; 2011 Jun; 39(6):1018-21. PubMed ID: 21466961
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life after thoracoscopic sympathectomy for palmar hyperhidrosis.
Kumagai K; Kawase H; Kawanishi M
Ann Thorac Surg; 2005 Aug; 80(2):461-6. PubMed ID: 16039186
[TBL] [Abstract][Full Text] [Related]
13. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
[TBL] [Abstract][Full Text] [Related]
14. Primary palmoplantar hyperhidrosis and thoracoscopic sympathectomy: a new objective assessment method.
Tetteh HA; Groth SS; Kast T; Whitson BA; Radosevich DM; Klopp AC; D'Cunha J; Maddaus MA; Andrade RS
Ann Thorac Surg; 2009 Jan; 87(1):267-74; discussion 274-5. PubMed ID: 19101310
[TBL] [Abstract][Full Text] [Related]
15. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage.
Bechara FG; Gambichler T; Bader A; Sand M; Altmeyer P; Hoffmann K
J Am Acad Dermatol; 2007 Aug; 57(2):207-12. PubMed ID: 17368632
[TBL] [Abstract][Full Text] [Related]
16. The effect of thoracoscopic sympathectomy on quality of life and symptom management of hyperhidrosis.
Boley TM; Belangee KN; Markwell S; Hazelrigg SR
J Am Coll Surg; 2007 Mar; 204(3):435-8. PubMed ID: 17324778
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
18. Update on pediatric hyperhidrosis.
Gordon JR; Hill SE
Dermatol Ther; 2013; 26(6):452-61. PubMed ID: 24552408
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy.
Roddy SP
J Vasc Surg; 2012 Jan; 55(1):291. PubMed ID: 22183006
[No Abstract] [Full Text] [Related]
20. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
Geddoa E; Balakumar AK; Paes TR
Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
